Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort forte Turbohaler crossover study of upper airway dimensions in COPD
2009-016502-16Phase 4Completed
- Sponsor
- University Hospital Antwerp : Department Respiratory Medicine
- Start
- Nov 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of budesonide and formoterol in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by University Hospital Antwerp : Department Respiratory Medicine. Primary endpoints: Total airway resistance, Total airway volume and 1 more. Started Nov 2009; status: completed.
02
Drugs
budesonideformoterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-016502-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016502-16.